Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia

OBJECTIVE: To examine neurodegenerative imaging biomarkers in Alzheimer disease (AD) dementia from middle to old age. METHODS: Persons with AD dementia and elevated brain β-amyloid with Pittsburgh compound B (PiB)-PET imaging underwent [(18)F]-fluorodeoxyglucose (FDG)-PET and structural MRI. We eval...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurology
Main Authors: Knopman, David S., Jack, Clifford R., Wiste, Heather J., Weigand, Stephen D., Vemuri, Prashanthi, Lowe, Val J., Kantarci, Kejal, Gunter, Jeffrey L., Senjem, Matthew L., Mielke, Michelle M., Machulda, Mary M., Roberts, Rosebud O., Boeve, Bradley F., Jones, David T., Petersen, Ronald C.
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4999168/
https://ncbi.nlm.nih.gov/pubmed/27421543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000002979
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares